Pharma Reviews: China is shopping for generics. Can Sun, Cipla, Alembic, and Aurobindo cash in?

Beijing has announced a raft of reforms for procuring generic drugs. This has renewed hope for Indian pharma companies, which in the last two ...
Read more: China is shopping for generics. Can Sun, Cipla, Alembic, and Aurobindo cash in?